Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin-Reference-Cited by-同舟云学术

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Published:2009-12 Issue:6 Volume:51 Page:984-990
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Grasso Alessandro,Malfatti Federica,Leo Pasqualina De,Martines Hugo,Fabris Paolo,Toscanini Federica,Anselmo Marco,Menardo Giorgio

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

2. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon-alpha-2a plus ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Int Med,2004

4. Early virologic response to treatment with peginterferon alpha-2b plus ribavirin in patients with chronic hepatitis C;Davis;Hepatology,2003

5. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alpha-2a (40 kDa)/ribavirin;Ferenci;J Hepatol,2005

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV;Beni-Suef University Journal of Basic and Applied Sciences;2023-01-05

2. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases;International Journal of Molecular Sciences;2022-09-14

3. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study;The Korean Journal of Internal Medicine;2020-09-01

4. Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection;Open Forum Infectious Diseases;2019-07-01

5. Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters;Cells;2019-03-15